{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Autonomic+Peripheral+Nervous+System+Diseases&page=9", "query": { "condition": "Autonomic Peripheral Nervous System Diseases", "page": 9 }, "page_size": 10 }, "pagination": { "page": 9, "page_size": 10, "total_count": 229, "total_pages": 23, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Autonomic+Peripheral+Nervous+System+Diseases&page=10&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Autonomic+Peripheral+Nervous+System+Diseases&page=8&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-11T12:28:49.895Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02276716", "title": "The Nutritional Supplement Phosphatidylserine in Patients With Familial Dysautonomia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Familial Dysautonomia" ], "interventions": [ { "name": "Phosphatidylserine", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 26, "start_date": "2011-11", "completion_date": "2019-08-01", "has_results": false, "last_update_posted_date": "2021-02-21", "last_synced_at": "2026-10-11T12:28:49.895Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02276716" }, { "nct_id": "NCT05103358", "title": "Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Tumor", "Tumor, Solid", "Metastasis", "Metastatic Cancer", "Cancer", "Cancer Metastatic", "Tumors", "Neoplasms", "Neoplasm Metastasis", "Solid Tumor", "Advanced Solid Tumor", "Advanced Cancer", "Malignant Solid Tumor", "Malignant Solid Neoplasm", "Malignant Neoplasm", "Malignant Tumor", "TSC", "TSC1", "TSC2", "Metastatic Solid Tumor", "Metastatic Neoplasm" ], "interventions": [ { "name": "nab-sirolimus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aadi Bioscience, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 128, "start_date": "2022-03-10", "completion_date": "2024-12-23", "has_results": true, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-11T12:28:49.895Z", "location_count": 159, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Goodyear, Arizona + 137 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Prescott Valley", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05103358" }, { "nct_id": "NCT04066933", "title": "Forms of Cervical Brachial Syndrome Treated With Plasma Concentrate Enriched for A2M", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Complex Regional Pain Syndromes", "Neuralgia", "Thoracic Outlet Neurologic Syndrome" ], "interventions": [ { "name": "A2M enriched plasma", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Neurological Associates of West Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "23 Years", "maximum_age": "77 Years", "sex": "ALL", "summary": "23 Years to 77 Years" }, "enrollment_count": 60, "start_date": "2018-09-24", "completion_date": "2023-12", "has_results": false, "last_update_posted_date": "2022-09-28", "last_synced_at": "2026-10-11T12:28:49.895Z", "location_count": 1, "location_summary": "Santa Monica, California", "locations": [ { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04066933" }, { "nct_id": "NCT04163419", "title": "Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schwannomatosis", "Pain" ], "interventions": [ { "name": "Tanezumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 9, "start_date": "2020-04-30", "completion_date": "2024-09-30", "has_results": false, "last_update_posted_date": "2024-03-13", "last_synced_at": "2026-10-11T12:28:49.895Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04163419" }, { "nct_id": "NCT03126019", "title": "A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lymphoma" ], "interventions": [ { "name": "Parsaclisib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 126, "start_date": "2018-03-14", "completion_date": "2024-06-07", "has_results": true, "last_update_posted_date": "2025-03-14", "last_synced_at": "2026-10-11T12:28:49.895Z", "location_count": 22, "location_summary": "Phoenix, Arizona • Beverly Hills, California • Los Angeles, California + 18 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Santa Rosa", "state": "California" }, { "city": "Whittier", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03126019" }, { "nct_id": "NCT02402530", "title": "Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Complex Regional Pain Syndrome, Type I" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Neridronic acid 62.5 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Grünenthal GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 459, "start_date": "2015-04", "completion_date": "2016-11", "has_results": false, "last_update_posted_date": "2018-05-09", "last_synced_at": "2026-10-11T12:28:49.895Z", "location_count": 49, "location_summary": "Foley, Alabama • Scottsdale, Arizona • Tucson, Arizona + 42 more", "locations": [ { "city": "Foley", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02402530" }, { "nct_id": "NCT05777889", "title": "Infrared Images for Spinal Cord Stimulation in Complex Regional Pain Syndrome Patients", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Complex Regional Pain Syndromes" ], "interventions": [ { "name": "Forward Looking InfraRed Camera", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Hospital for Special Surgery, New York", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 12, "start_date": "2023-02-22", "completion_date": "2027-02", "has_results": false, "last_update_posted_date": "2025-11-26", "last_synced_at": "2026-10-11T12:28:49.895Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05777889" }, { "nct_id": "NCT03094832", "title": "Study of Miransertib (MK-7075) in Participants With PIK3CA-related Overgrowth Spectrum and Proteus Syndrome (MOSAIC) (MK-7075-002)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome" ], "interventions": [ { "name": "Miransertib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 50, "start_date": "2017-05-16", "completion_date": "2022-04-11", "has_results": true, "last_update_posted_date": "2023-04-13", "last_synced_at": "2026-10-11T12:28:49.895Z", "location_count": 6, "location_summary": "Atlanta, Georgia • Chicago, Illinois • Boston, Massachusetts + 3 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03094832" }, { "nct_id": "NCT04849897", "title": "Virtual Reality Guided Imagery for Chronic Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Complex Regional Pain Syndromes", "Back Pain" ], "interventions": [ { "name": "Experimental: Virtual Reality Guided Imagery", "type": "DEVICE" }, { "name": "Active Comparator: Audio Only Guided Imagery", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2021-03-22", "completion_date": "2022-04-30", "has_results": true, "last_update_posted_date": "2024-08-21", "last_synced_at": "2026-10-11T12:28:49.895Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04849897" }, { "nct_id": "NCT05945147", "title": "Ketamine and Midazolam Infusions for CRPS: Feasibility Study", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Complex Regional Pain Syndromes" ], "interventions": [ { "name": "Ketamine", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" }, { "name": "Normal Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2099-01-01", "completion_date": "2099-05-31", "has_results": false, "last_update_posted_date": "2024-11-22", "last_synced_at": "2026-10-11T12:28:49.895Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05945147" } ] }